China Liposomes Drug Delivery Market Report 2021

November 2016 | 105 pages | ID: CC7E2EA826EEN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Liposomes Drug Delivery

Revenue, means the sales value of Liposomes Drug Delivery

This report studies sales (consumption) of Liposomes Drug Delivery in China market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• Enzon
• Gilead Sciences
• Pacira
• Teva Pharmaceutical
• Crucell N.V.
• Chiesi Farmaceutici, S.p.A.
• Novartis
• Janssen Biotech
• Novavax
• Spectrum Pharmaceuticals

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Non-interactive sterically stabilized (long- circulating) liposomes(LCL)
• Highly interactive cationic liposomes
• Type III

Split by applications, this report focuses on sales, market share and growth rate of Liposomes Drug Delivery in each application, can be divided into

• Ocular Applications
• Pulmonary Applications
• Cancer Therapy

Contents

China Liposomes Drug Delivery Sales Market Report 2021

1 LIPOSOMES DRUG DELIVERY OVERVIEW

1.1 Product Overview and Scope of Liposomes Drug Delivery
1.2 Classification of Liposomes Drug Delivery
  1.2.11 Non-interactive sterically stabilized (long- circulating) liposomes(LCL)
  1.2.12 Highly interactive cationic liposomes
  1.2.3 Type III
1.3 Applications of Liposomes Drug Delivery
  1.3.11 Ocular Applications
  1.3.12 Pulmonary Applications
  1.3.13 Cancer Therapy
1.4 China Market Size (Value and Volume) of Liposomes Drug Delivery (2011-2021)
  1.4.1 China Liposomes Drug Delivery Sales, Revenue and Price (2011-2021)
  1.4.2 China Liposomes Drug Delivery Sales and Growth Rate (2011-2021)
  1.4.3 China Liposomes Drug Delivery Revenue and Growth Rate (2011-2021)

2 CHINA LIPOSOMES DRUG DELIVERY COMPETITION BY MANUFACTURERS

2.1 China Liposomes Drug Delivery Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 China Liposomes Drug Delivery Revenue and Share by Manufactures (2015 and 2016)

3 CHINA LIPOSOMES DRUG DELIVERY (VOLUME AND VALUE) BY TYPE

3.1 China Liposomes Drug Delivery Sales and Market Share by Type (2011-2021)
3.2 China Liposomes Drug Delivery Revenue and Market Share by Type (2011-2021)

4 CHINA LIPOSOMES DRUG DELIVERY (VOLUME) BY APPLICATION

5 CHINA LIPOSOMES DRUG DELIVERY MANUFACTURERS ANALYSIS

5.1 Enzon
  5.1.1 Company Basic Information, Manufacturing Base and Competitors
  5.1.2 Liposomes Drug Delivery Product Type and Technology
    5.1.2.1 Non-interactive sterically stabilized (long- circulating) liposomes(LCL)
    5.1.2.2 Highly interactive cationic liposomes
  5.1.3 Liposomes Drug Delivery Sales, Revenue, Price of Enzon (2015 and 2016)
5.2 Gilead Sciences
  5.2.1 Company Basic Information,Manufacturing Base and Competitors
  5.2.2 Pharma & Healthcare Product Type and Technology
    5.2.2.1 Non-interactive sterically stabilized (long- circulating) liposomes(LCL)
    5.2.2.2 Highly interactive cationic liposomes
  5.2.3 Pharma & Healthcare Sales, Revenue, Price of Gilead Sciences (2015 and 2016)
5.3 Pacira
  5.3.1 Company Basic Information,Manufacturing Base and Competitors
  5.3.2 Pacira Product Type and Technology
    5.3.2.1 Non-interactive sterically stabilized (long- circulating) liposomes(LCL)
    5.3.2.2 Highly interactive cationic liposomes
  5.3.3 Pacira Sales, Revenue, Price of Pacira (2015 and 2016)
5.4 Teva Pharmaceutical
  5.4.1 Company Basic Information,Manufacturing Base and Competitors
  5.4.2 Novavax Product Type and Technology
    5.4.2.1 Non-interactive sterically stabilized (long- circulating) liposomes(LCL)
    5.4.2.2 Highly interactive cationic liposomes
  5.4.3 Teva Pharmaceutical Sales, Revenue, Price of Teva Pharmaceutical (2015 and 2016)
5.5 Crucell N.V.
  5.5.1 Company Basic Information,Manufacturing Base and Competitors
  5.5.2 Crucell N.V. Product Type and Technology
    5.5.2.1 Non-interactive sterically stabilized (long- circulating) liposomes(LCL)
    5.5.2.2 Highly interactive cationic liposomes
  5.5.3 Crucell N.V. Sales, Revenue, Price of Crucell N.V. (2015 and 2016)
5.6 Chiesi Farmaceutici, S.p.A.
  5.6.1 Company Basic Information,Manufacturing Base and Competitors
  5.6.2 Chiesi Farmaceutici, S.p.A. Product Type and Technology
    5.6.2.1 Non-interactive sterically stabilized (long- circulating) liposomes(LCL)
    5.6.2.2 Highly interactive cationic liposomes
  5.6.3 Chiesi Farmaceutici, S.p.A. Sales, Revenue, Price of Chiesi Farmaceutici, S.p.A. (2015 and 2016)
5.7 Novartis
  5.7.1 Company Basic Information,Manufacturing Base and Competitors
  5.7.2 Novartis Product Type and Technology
    5.7.2.1 Non-interactive sterically stabilized (long- circulating) liposomes(LCL)
    5.7.2.2 Highly interactive cationic liposomes
  5.7.3 Novartis Sales, Revenue, Price of Novartis (2015 and 2016)
5.8 Janssen Biotech
  5.8.1 Company Basic Information,Manufacturing Base and Competitors
  5.8.2 Janssen Biotech Product Type and Technology
    5.8.2.1 Non-interactive sterically stabilized (long- circulating) liposomes(LCL)
    5.8.2.2 Highly interactive cationic liposomes
  5.8.3 Janssen Biotech Sales, Revenue, Price of Janssen Biotech (2015 and 2016)
5.9 Novavax
  5.9.1 Company Basic Information,Manufacturing Base and Competitors
  5.9.2 Novavax Product Type and Technology
    5.9.2.1 Non-interactive sterically stabilized (long- circulating) liposomes(LCL)
    5.9.2.2 Highly interactive cationic liposomes
  5.9.3 Novavax Sales, Revenue, Price of Novavax (2015 and 2016)
5.10 Spectrum Pharmaceuticals
  5.10.1 Company Basic Information,Manufacturing Base and Competitors
  5.10.2 Spectrum Pharmaceuticals Product Type and Technology
    5.10.2.1 Non-interactive sterically stabilized (long- circulating) liposomes(LCL)
    5.10.2.2 Highly interactive cationic liposomes
  5.10.3 Spectrum Pharmaceuticals Sales, Revenue, Price of Spectrum Pharmaceuticals (2015 and 2016)

6 LIPOSOMES DRUG DELIVERY TECHNOLOGY AND DEVELOPMENT TREND

6.1 Liposomes Drug Delivery Technology Analysis
6.2 Liposomes Drug Delivery Technology Development Trend

7 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Liposomes Drug Delivery
Table Classification of Liposomes Drug Delivery
Figure China Sales Market Share of Liposomes Drug Delivery by Type in 2015
Figure Non-interactive sterically stabilized (long- circulating) liposomes(LCL) Picture
Figure Highly interactive cationic liposomes Picture
Table Applications of Liposomes Drug Delivery
Figure China Sales Market Share of Liposomes Drug Delivery by Application in 2015
Figure Ocular Applications Examples
Figure Pulmonary Applications Examples
Figure Cancer Therapy Examples
Table China Liposomes Drug Delivery Sales, Revenue and Price (2011-2021)
Figure China Liposomes Drug Delivery Sales and Growth Rate (2011-2021)
Figure China Liposomes Drug Delivery Revenue and Growth Rate (2011-2021)
Table China Liposomes Drug Delivery Sales of Key Manufacturers (2015 and 2016)
Table China Liposomes Drug Delivery Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Liposomes Drug Delivery Sales Share by Manufacturers
Figure 2016 Liposomes Drug Delivery Sales Share by Manufacturers
Table China Liposomes Drug Delivery Revenue by Manufacturers (2015 and 2016)
Table China Liposomes Drug Delivery Revenue Share by Manufacturers (2015 and 2016)
Table 2015 China Liposomes Drug Delivery Revenue Share by Manufacturers
Table 2016 China Liposomes Drug Delivery Revenue Share by Manufacturers
Table China Liposomes Drug Delivery Sales and Market Share by Type (2011-2021)
Table China Liposomes Drug Delivery Sales Share by Type (2011-2021)
Figure Sales Market Share of Liposomes Drug Delivery by Type (2011-2021)
Figure China Liposomes Drug Delivery Sales Growth Rate by Type (2011-2021)
Table China Liposomes Drug Delivery Revenue and Market Share by Type (2011-2021)
Table China Liposomes Drug Delivery Revenue Share by Type (2011-2021)
Figure Revenue Market Share of Liposomes Drug Delivery by Type (2011-2021)
Figure China Liposomes Drug Delivery Revenue Growth Rate by Type (2011-2021)
Table China Liposomes Drug Delivery Sales and Market Share by Application (2011-2021)
Table China Liposomes Drug Delivery Sales Share by Application (2011-2021)
Figure Sales Market Share of Liposomes Drug Delivery by Application (2011-2021)
Figure China Liposomes Drug Delivery Sales Growth Rate by Application (2011-2021)
Table Enzon Basic Information List
Table Liposomes Drug Delivery Sales, Revenue, Price of Enzon (2015 and 2016)
Table Gilead Sciences Basic Information List
Table Liposomes Drug Delivery Sales, Revenue, Price of Gilead Sciences (2015 and 2016)
Table Pacira Basic Information List
Table Liposomes Drug Delivery Sales, Revenue, Price of Pacira (2015 and 2016)
Table Teva Pharmaceutical Basic Information List
Table Liposomes Drug Delivery Sales, Revenue, Price of Teva Pharmaceutical (2015 and 2016)
Table Crucell N.V. Basic Information List
Table Liposomes Drug Delivery Sales, Revenue, Price of Crucell N.V. (2015 and 2016)
Table Chiesi Farmaceutici, S.p.A. Basic Information List
Table Liposomes Drug Delivery Sales, Revenue, Price of Chiesi Farmaceutici, S.p.A. (2015 and 2016)
Table Novartis Basic Information List
Table Liposomes Drug Delivery Sales, Revenue, Price of Novartis (2015 and 2016)
Table Janssen Biotech Basic Information List
Table Liposomes Drug Delivery Sales, Revenue, Price of Janssen Biotech (2015 and 2016)
Table Novavax Basic Information List
Table Liposomes Drug Delivery Sales, Revenue, Price of Novavax (2015 and 2016)
Table Spectrum Pharmaceuticals Basic Information List
Table Liposomes Drug Delivery Sales, Revenue, Price of Spectrum Pharmaceuticals (2015 and 2016)